Transition of Sézary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis

Journal of Clinical Pathology

Volumn 57, Issue 12, 2004, Pages 1325-1328

  Assaf, C ^a   Hummel, M ^a   Zemlin, M ^b   Steinhoff, M ^a   Geilen, C C ^a   Stein, H ^a   Orfanos, C E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

AGED; ARTICLE; CASE REPORT; EXTRACORPOREAL CIRCULATION; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; MALE; MYCOSIS FUNGOIDES; PERIPHERAL CIRCULATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUVA; REMISSION; SEZARY SYNDROME; SKIN BIOPSY; SKIN LYMPHOMA;

AGED; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; LYMPHOMA, LARGE-CELL; MALE; MYCOSIS FUNGOIDES; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; SEZARY SYNDROME;

EID: 10044278263     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.017160     Document Type: Article

References (25)

1. Siegel RS, Pandolfino T, Guitart J, et al. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 2000;18:2908-25.
2. Kim YH, Liu HL, Mraz-Gernhard S, et al. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003;139:857-66.
3. Kim YH, Hoppe RT. Mycosis fungoides and the Sézary syndrome. Semin Oncol 1999;26:276-89.
4. Saed G, Fivenson DP, Naidu Y, et al. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sézary syndrome expresses a Th2-type profile. J Invest Dermatol 1994;103:29-33.
5. Zemlin M, Hummel M, Anagnostapoulos I, et al. Improved polymerase chain reaction detection of clorially rearranged T-cell receptor beta chain genes. Diagn Mol Pathol 1998;7:138-45.
6. Assaf C, Hummel M, Dippel E, et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA-sequencing. Blood 2000;96:640-6.
7. Dippel E, Assaf C, Hummel M, et al. Clonal T-cell receptor γ-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol 1999;188:146-54.
8. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organisation classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
9. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95-106.
10. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
11. Diamandidou E, Colome-Grimmer M, Fayad L, et al. Transformation of mycosis fungoides/Sézary syndrome: clinical characteristics and prognosis. Blood 1998;92:1150-9.
12. Kienitz T, Burg G, Schmoeckel C, et al. High-grade malignant lymphoma arising from Sézary's syndrome. A case report. Dermatologica 1979;158:126-36.
13. Sakai H, Matsuo S, Matsumoto M, et al. A case of Sézary syndrome associated with cutaneous transformation. J Dermatol 1996;23:697-702.
14. Carrozza PM, Kempf W, Kazakov DV, et al. A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma. Br J Dermatol 2002;147:582-6.
15. Marafioti T, Hummel M, Anagnostopoulos I, et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 1999;17:3804-9.
16. Chott A, Vonderheid EC, Olbricht S, et al. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid populosis. J Invest Dermatol 1996;106:696-700.
17. Steinhoff M, Hummel M, Anagnostopoulos I, et al. Single-cell analysis of CD30+ cells in lymphomatoid populosis demonstrates a common clonal T-cell origin. Blood 2002;100:578-84.
18. Assaf C, Hummel M, Dippel E, et al. Common clonal T-cell origin in a patient with T prolymphocytic leukaemia and associated cutaneous T-cell lymphomas. Br J Haematol 2003;120:488-91.
19. Macheiner W, Jantschitsch C, Graninger W, et al. Sézary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy. J Am Acad Dermatol 2003;48:220-6.
20. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987;5:297-303.
21. Yoo EK, Cassin M, Lessin SR, et al. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol 2001;45:208-16.
22. Dippel E, Goerdt S, Assaf C, et al. Cutaneous T-cell lymphoma severity index and T-cell gene rearrangement. Lancet 1997;350:1776-7.
23. Bladon J, Taylor PC. Extracorporeal pholopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Dermatol 2002;146:59-68.
24. Tambur AR, Ortegel JW, Morales A, et al. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis. Transplant Proc 2000;32:747-8.
25. Di Renzo M, Rubegni P, De Aloe G, et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology 1997;92:99-103.